8-K
Current Report
Prelude Therapeutics Inc Filed Acc 0000929638-25-004115
Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading a8k.htm…